Prolung

Early-stage lung cancer risk test based on bioconductance technology

placeSalt Lake City, Utah, United States calendar_todayFounded 2004 groups6 employees language prolunginc.com

Innovation

2 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 45 times.

YearFilings
20181
20231
Coming soon